- Home
- NYMT vs HUMA Comparison
NYMT vs HUMA Comparison
Compare NYMT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMT
- HUMA
- Stock Information
- Founded
- NYMT 2003
- HUMA 2004
- Country
- NYMT United States
- HUMA United States
- Employees
- NYMT N/A
- HUMA N/A
- Industry
- NYMT Real Estate Investment Trusts
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- NYMT Real Estate
- HUMA Health Care
- Exchange
- NYMT Nasdaq
- HUMA Nasdaq
- Market Cap
- NYMT 516.8M
- HUMA 577.7M
- IPO Year
- NYMT 2004
- HUMA N/A
- Fundamental
- Price
- NYMT $5.97
- HUMA $4.41
- Analyst Decision
- NYMT Buy
- HUMA Strong Buy
- Analyst Count
- NYMT 5
- HUMA 7
- Target Price
- NYMT $7.13
- HUMA $13.43
- AVG Volume (30 Days)
- NYMT 876.0K
- HUMA 8.3M
- Earning Date
- NYMT 02-19-2025
- HUMA 11-08-2024
- Dividend Yield
- NYMT 13.40%
- HUMA N/A
- EPS Growth
- NYMT N/A
- HUMA N/A
- EPS
- NYMT N/A
- HUMA N/A
- Revenue
- NYMT $252,541,000.00
- HUMA N/A
- Revenue This Year
- NYMT N/A
- HUMA N/A
- Revenue Next Year
- NYMT $45.89
- HUMA $5,584.53
- P/E Ratio
- NYMT N/A
- HUMA N/A
- Revenue Growth
- NYMT 139.48
- HUMA N/A
- 52 Week Low
- NYMT $5.14
- HUMA $2.55
- 52 Week High
- NYMT $8.51
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- NYMT 49.00
- HUMA 46.34
- Support Level
- NYMT $5.53
- HUMA $4.02
- Resistance Level
- NYMT $5.99
- HUMA $4.67
- Average True Range (ATR)
- NYMT 0.17
- HUMA 0.40
- MACD
- NYMT -0.01
- HUMA -0.05
- Stochastic Oscillator
- NYMT 51.16
- HUMA 23.78
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.